The canadian Ministry of health warns: two well-known drug used for the treatment of benign hyperplasia (enlargement) of the prostate and baldness, significantly increase the risk of developing prostate cancer aggressive nature, the Agency CTV.
Under the sight of the doctors were drugs dutasteride and finasteride after analyses of two large-scale studies (Reduction by Dutasteride of Prostate Cancer Events and Prostate Cancer Prevention Trial), which, incidentally, were called to be proof positive effects of the above medications for prostate cancer.
Thanks to the research the following results were achieved: daily long-term use 5 milligrams of dutasteride and finasteride in men 50 years and older statistically significantly increased the risk of aggressive form of cancer. Finasteride at a dose of 1 milligram was not included in the testing, but experts do not exclude the danger of this volume.
It should be noted that in August of last year, the Ministry of health have said that finasteride in both volumes (1 and 5 mg) also increases men's risk of developing breast cancer. Then the manufacturers of generics finasteride has been on the label, add the appropriate marking. Now, they again need to update the labels on the drugs.